Viewing Study NCT00207766


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-02-06 @ 1:30 PM
Study NCT ID: NCT00207766
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Sponsor: Centocor, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Crohn's Disease View
None infusions View